Akums Drugs and Pharmaceuticals Limited

AKUMS

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 2026395

    Quarter₹ croreYoY
    Sept 2024328—
    Dec 2024337—
    Mar 2025329—
    Jun 2025332+4.8%
    Sept 2025309-5.8%
    Dec 2025369+9.2%
    Mar 2026338+2.9%
    Jun 2026392+18.0%
    Sept 2026395+27.7%
  • ₹ crore

    Sept 202626

    Quarter₹ crore
    Sept 202432
    Dec 202434
    Mar 202532
    Jun 202529
    Sept 202527
    Dec 202530
    Mar 202628
    Jun 202626
    Sept 202626
  • ₹ crore

    Sept 2026421

    Quarter₹ crore
    Sept 2024360
    Dec 2024371
    Mar 2025361
    Jun 2025361
    Sept 2025336
    Dec 2025398
    Mar 2026366
    Jun 2026418
    Sept 2026421
  • Cost structure
  • ₹ crore

    Sept 202665

    Quarter₹ crore
    Sept 202450
    Dec 202450
    Mar 202554
    Jun 202551
    Sept 202555
    Dec 202555
    Mar 202658
    Jun 202659
    Sept 202665
  • ₹ crore

    Sept 2026377

    Quarter₹ crore
    Sept 2024299
    Dec 2024316
    Mar 2025324
    Jun 2025301
    Sept 2025305
    Dec 2025359
    Mar 2026342
    Jun 2026359
    Sept 2026377
  • Exceptional items and tax
  • ₹ crore

    Sept 202644

    Quarter₹ crore
    Sept 202462
    Dec 202455
    Mar 202537
    Jun 202560
    Sept 202531
    Dec 202536
    Mar 202622
    Jun 202659
    Sept 202644
  • ₹ crore

    Sept 202611

    Quarter₹ crore
    Sept 202411
    Dec 202414
    Mar 20259
    Jun 202515
    Sept 20258
    Dec 20258
    Mar 20267
    Jun 202614
    Sept 202611
  • Profit
  • ₹ crore

    Sept 202633

    Quarter₹ croreYoY
    Sept 202450—
    Dec 202441—
    Mar 202528—
    Jun 202545+7.1%
    Sept 202523-53.4%
    Dec 202528-31.7%
    Mar 202615-44.9%
    Jun 202645-0.1%
    Sept 202633+39.1%
  • Per share
  • ₹ per share

    Sept 20262.13

    Quarter₹ per share
    Sept 20243.38
    Dec 20242.69
    Mar 20251.80
    Jun 20252.93
    Sept 20251.53
    Dec 20251.84
    Mar 20260.99
    Jun 20262.93
    Sept 20262.13
  • Leverage
  • Debt to equity

    times

    Sept 20240.00x

    Quartertimes
    Sept 20240.00x
    Dec 2024—
    Mar 2025—
    Jun 2025—
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
    Sept 2026—
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
328337329332309369338392395
Revenue YoY———+4.8%-5.8%+9.2%+2.9%+18.0%+27.7%
323432292730282626
360371361361336398366418421
Cost structure
505054515555585965
299316324301305359342359377
Exceptional items and tax
625537603136225944
11149158871411
Profit
504128452328154533
Net profit YoY———+7.1%-53.4%-31.7%-44.9%-0.1%+39.1%
Per share
3.382.691.802.931.531.840.992.932.13
Leverage
Debt to equity0.00x————————

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.